Nasobec (Beclometasone Dipropionate)

Beclometasone Dipropionate, the active ingredient in Nasobec, is a corticosteroid (Glucocorticoid) presented as a nasal spray for endosinusial use. It is indicated for the management of allergic rhinitis, nasal polyps and chronic sinusitis in patients requiring local anti‑inflammatory therapy.

GNH USA supplies Nasobec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Beclometasone Dipropionate acts locally in the nasal mucosa to control inflammation associated with several upper‑respiratory conditions. - Allergic rhinitis: reduces nasal congestion, itching and sneezing by suppressing inflammatory mediators. - Nasal polyps: decreases polyp size and improves airflow through anti‑inflammatory action. - Chronic sinusitis: alleviates sinus inflammation and promotes symptom relief.

Adverse reactions are generally mild and related to local exposure, but systemic effects can occur with excessive use.

Common Side Effects: - Nasal irritation or burning sensation. - Epistaxis (nosebleeds). - Altered taste or throat irritation. - Headache. - Dryness of nasal passages.

Serious or Rare Side Effects: - Fungal infection of the nasal cavity. - Adrenal suppression with prolonged high‑dose use. - Severe or persistent nosebleeds. - Vision changes such as cataracts or glaucoma. - Anaphylactic or severe allergic reactions.

Before initiating therapy, consider the following safety measures. - Assess for active nasal or sinus infection: avoid use until infection is controlled. - Use the lowest effective dose: limit duration to the prescribed period. - Monitor for signs of adrenal suppression: especially in children or with high‑dose regimens. - Avoid concurrent systemic corticosteroids unless medically necessary. - Caution in patients with glaucoma or cataracts: monitor ocular pressure. - Store at room temperature: keep in the original container, protect from moisture and heat.

Beclometasone Dipropionate may interact with other medicines that affect steroid metabolism or immune function.

Major Interactions (Avoid): - Concomitant systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Live vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may raise local steroid exposure. - Antifungal agents used intranasally: risk of additive irritation. - Nasal decongestants: may mask underlying infection, requiring careful assessment.